Less bystander CPR done in poor, black neighborhoods, study shows
(HealthDay)—People whose hearts stop abruptly are only half as likely to be given bystander-initiated CPR in poor black neighborhoods as they are in higher-income white areas, a new study indicates.
View ArticleScientists identify new biomarker for cancer in bone marrow: Promise for...
Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of...
View ArticleGame changing diagnostic and prognostic prostate cancer genetic tests revealed
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and...
View ArticleReal-world patient survival with defibrillators matches trial expectations
Patients who received an implantable heart defibrillator in everyday practice had survival benefits on par with those who received the same devices in carefully controlled clinical trials, according to...
View ArticleCervical cancer patients more likely to survive if treated at high-volume...
Patients with locally advanced cervical cancer have better treatment outcomes and are more likely to survive the disease if they receive care at a high-volume medical center than patients treated at...
View ArticleHPV improves survival for African-Americans with throat cancer
Even though the human papillomavirus (HPV) is a risk factor for certain head and neck cancers, its presence could make all the difference in terms of survival, especially for African Americans with...
View ArticleInitiation of breast cancer treatment varies by race; patient-doctor...
Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days—a time delay associated with increased deaths from the...
View ArticleOlder prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by...
View ArticlePretesting cervical tumors could inform treatment
(Medical Xpress)—Doctors at Washington University School of Medicine in St. Louis have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients...
View ArticleRadiopeptide therapy improves survival outcomes for neuroendocrine cancer...
Peptide-receptor radionuclide therapy (PRRT) has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to...
View ArticleProtein called FAIM could help doctors to parse which cancer patients will...
A number of drugs exist that can extend the lifespan of people with multiple myeloma (MM), but none of these medicines are curative. Thus, medical researchers continue to search for targets for new...
View ArticleEncouraging outcomes for pediatric brain tumor patients treated with proton...
When used to treat pediatric patients with intracranial malignant tumors, proton therapy may limit the toxicity of radiation therapy while preserving tumor control, according to research presented...
View ArticleOvarian cancer discovery deepens knowledge of survival outcomes
Researchers in the Women's Cancer Program at Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute have identified a series of 10 genes that may signify a trifecta of benefits for women diagnosed...
View ArticleKidney cancer care improves with vaccine-based approach
The Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute has opened a novel Phase III, vaccine-based clinical trial aimed at providing kidney cancer patients long-term control of their disease.
View ArticleHepatitis C reactivation doesn't worsen survival for HIV+ patients diagnosed...
More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications...
View ArticleMarginal life expectancy benefit from contralateral prophylactic mastectomy
The choice of contralateral prophylactic mastectomy (CPM) by women with breast cancer (BC) diagnosed in one breast has recently increased in the US but may confer only a marginal life expectancy...
View ArticleSurgery associated with better survival for patients with advanced laryngeal...
Patients with advanced laryngeal cancer appear to have better survival if they are treated with surgery than nonsurgical chemoradiation.
View ArticleImproved survival shown in early-stage Hodgkin's Disease patients who receive...
Patients with stage I and II Hodgkin's Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive...
View ArticleRates of procedures such as angioplasty lower in states with public reporting...
In an analysis that included nearly 100,000 Medicare patients who had experienced a heart attack, the use of a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent...
View ArticleBreast surgery options flex to meet personalized needs of women
With a plethora of advice from websites and survivor support networks as well as friends, family and co-workers, it can seem daunting to make the "right" decision when facing breast cancer.
View ArticleASH international clinical collaboration replicates high cure rate of APL in...
Data published online today in Blood, the Journal of the American Society of Hematology (ASH) describe the work of an ASH international clinical network collaborative focused on modernizing treatment...
View ArticleBetter long-term outcomes with low hep C viral load
(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of...
View ArticleA phone call can change your life, study finds
They say a phone call can change your life and for colorectal or bowel cancer survivors this is true, a new study by a QUT researcher has found.
View ArticleCampaign increases first-time mouth and throat cancer screenings among...
Raising awareness of the dangers of mouth and throat cancer increased the number of black men in some of Florida's poorest counties who sought screening for the first time, opening the door to improved...
View ArticleTeam links gene expression, immune system with cancer survival rates
Physicians have long sought a way to accurately predict cancer patients' survival outcomes by looking at biological details of the specific cancers they have. But despite concerted efforts, no such...
View ArticleDiscovery improves profiling of AML patients for targeted therapies
Testing for DNMT3A mutations in FLT3-ITD subgroup of AML patients at the point of diagnosis and post-chemotherapy could improve treatment and predict chances of relapse and survival rates respectively
View ArticleMethylation of gene panel may help predict breast CA survival
(HealthDay)—Methylation of a gene panel is a strong predictor of survival outcomes in metastatic breast cancer (MBC), according to a study published online Nov. 21 in the Journal of Clinical Oncology.
View ArticleSite of care may partly explain survival difference between kids and AYAs...
Adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) who were not treated at specialized cancer centers had significantly worse five-year...
View ArticleFindings support use of less invasive hysterectomy for early-stage...
Researchers found similar rates of disease-free survival and no difference in overall survival among women who received a laparoscopic or abdominal total hysterectomy for stage I endometrial cancer,...
View ArticleDNA-level biomarker can predict overall survival for rare brain tumors
MGMT promoter methylation status—information gathered at a DNA-level—can help predict overall survival for patients with a rare form of brain cancer known as anaplastic astrocytoma, according to a new...
View Article
